Receptor activation triggers a PLC-IP3-Ca2+ cascade leading to rapid pulsatile release of GH stored in secretion granules
November 22 Product: Generic exenatide Indication: Type 2 diabetes The highly lucrative and competitive GLP-1 space on Friday welcomed one of its first generic entrants with the FDAs approval of Amneal Pharmaceuticals exenatide, a copycat version of AstraZenecas Byetta
doi: 10.1126/scitranslmed.aah4477 Summary Keywords metabolic syndrome, atherosclerotic cardiovascular disease, hypertension, endothelial dysfunction, platelet hyperactivity Citation Das D, Shruthi NR, Banerjee A, Jothimani G, Duttaroy AK and Pathak S (2023) Endothelial dysfunction, platelet hyperactivity, hypertension, and the metabolic syndrome: molecular insights and combating strategies
[9] Guevara-Campos J, Gonzlez-Guevara L, Guevara-Gonzlez J, Cauli O
6B, and Supplementary Data 35)